beta-Alanine and gamma-aminobutyric acid contents of rat brain; post-mortem changes and effects of aminooxyacetic acid and di-n-propylacetate. 1978

R Martin del Rio, and M García-Gracia, and L M Orensanz Muñoz, and F V DeFeudis

UI MeSH Term Description Entries
D008297 Male Males
D011180 Postmortem Changes Physiological changes that occur in bodies after death. Adipocere,Algor Mortis,Cruor,Livor Mortis,Change, Postmortem,Changes, Postmortem,Postmortem Change
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt
D000409 Alanine A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM. Abufène,Alanine, L-Isomer,L-Alanine,Alanine, L Isomer,L Alanine,L-Isomer Alanine
D000612 4-Aminobutyrate Transaminase An enzyme that converts brain gamma-aminobutyric acid (GAMMA-AMINOBUTYRIC ACID) into succinate semialdehyde, which can be converted to succinic acid and enter the citric acid cycle. It also acts on beta-alanine. EC 2.6.1.19. Aminobutyrate Aminotransferase,GABA Transaminase,beta-Alanine Ketoglutarate Aminotransferase,GABA Aminotransferase,GABA-alpha-Ketoglutarate Aminotransferase,4 Aminobutyrate Transaminase,Aminotransferase, Aminobutyrate,Aminotransferase, GABA,Aminotransferase, GABA-alpha-Ketoglutarate,Aminotransferase, beta-Alanine Ketoglutarate,GABA alpha Ketoglutarate Aminotransferase,Ketoglutarate Aminotransferase, beta-Alanine,Transaminase, 4-Aminobutyrate,Transaminase, GABA,beta Alanine Ketoglutarate Aminotransferase
D000613 Aminobutyrates Derivatives of BUTYRIC ACID that contain one or more amino groups attached to the aliphatic structure. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the aminobutryrate structure. Aminobutyric Acids,Aminobutyric Acid,Acid, Aminobutyric,Acids, Aminobutyric
D000625 Aminooxyacetic Acid A compound that inhibits aminobutyrate aminotransferase activity in vivo, thereby raising the level of gamma-aminobutyric acid in tissues. Aminooxyacetate,Carboxymethoxyamine,Acid, Aminooxyacetic
D000637 Transaminases A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Most of these enzymes are pyridoxyl phosphate proteins. (Dorland, 28th ed) EC 2.6.1. Aminotransferase,Aminotransferases,Transaminase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

R Martin del Rio, and M García-Gracia, and L M Orensanz Muñoz, and F V DeFeudis
December 1981, Journal of neurochemistry,
R Martin del Rio, and M García-Gracia, and L M Orensanz Muñoz, and F V DeFeudis
June 1977, Experimental brain research,
R Martin del Rio, and M García-Gracia, and L M Orensanz Muñoz, and F V DeFeudis
March 1976, British journal of pharmacology,
R Martin del Rio, and M García-Gracia, and L M Orensanz Muñoz, and F V DeFeudis
January 1983, General pharmacology,
R Martin del Rio, and M García-Gracia, and L M Orensanz Muñoz, and F V DeFeudis
April 1981, Japanese journal of pharmacology,
R Martin del Rio, and M García-Gracia, and L M Orensanz Muñoz, and F V DeFeudis
March 1953, The Journal of biological chemistry,
R Martin del Rio, and M García-Gracia, and L M Orensanz Muñoz, and F V DeFeudis
September 1966, Science (New York, N.Y.),
R Martin del Rio, and M García-Gracia, and L M Orensanz Muñoz, and F V DeFeudis
June 1974, Journal of neurochemistry,
R Martin del Rio, and M García-Gracia, and L M Orensanz Muñoz, and F V DeFeudis
July 1953, The Journal of biological chemistry,
R Martin del Rio, and M García-Gracia, and L M Orensanz Muñoz, and F V DeFeudis
May 1966, Biochemical pharmacology,
Copied contents to your clipboard!